{"entity":{"type":"insider","cik":"0001360968","url":"/insider/0001360968","json_url":"/insider/0001360968.json","name":"MILBY RANDY","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":31,"first":"2006-09-15","last":"2024-12-20","span_basis":"filed_date"},"name_variants":[{"name":"MILBY RANDY","source":"filing","n_filings":31,"first_seen":"2006-09-15","last_seen":"2024-12-20"}],"transactions":[{"id":2692968,"accession":"0001493152-24-051134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-051134","line_url":"/filing/0001493152-24-051134#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"Tharimmune, Inc.","issuer_ticker":"THAR","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4600.0,"shares_display":"4,600","price_per_share":2.12,"price_display":"2.12","price_state":"stated","total_value":9752.0,"total_display":"9,752.00","total_whole":"9,752","shares_owned_after":17534.0,"shares_owned_after_display":"17,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-19","filed_date":"2024-12-20","scope":"insider"},{"id":2630753,"accession":"0001493152-24-040736","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-24-040736","line_url":"/filing/0001493152-24-040736","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"Tharimmune, Inc.","issuer_ticker":"THAR","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.088416,"price_display":"2.09","price_state":"stated","total_value":5221.04,"total_display":"5,221.04","total_whole":"5,221","shares_owned_after":11934.0,"shares_owned_after_display":"11,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-08","filed_date":"2024-10-10","scope":"insider","n_lines":3},{"id":8208766,"accession":"0001493152-23-045215","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-045215","line_url":"/filing/0001493152-23-045215#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"Tharimmune, Inc.","issuer_ticker":"THAR","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29000.0,"shares_display":"29,000","price_per_share":0.503,"price_display":"0.50","price_state":"stated","total_value":14587.0,"total_display":"14,587.00","total_whole":"14,587","shares_owned_after":156517.0,"shares_owned_after_display":"156,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-18","scope":"insider"},{"id":8734598,"accession":"0001493152-23-043560","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-043560","line_url":"/filing/0001493152-23-043560#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"Tharimmune, Inc.","issuer_ticker":"THAR","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":127517.0,"shares_owned_after_display":"127,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-04","scope":"insider"},{"id":6155584,"accession":"0001493152-22-017377","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-017377","line_url":"/filing/0001493152-22-017377#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"Hillstream BioPharma Inc.","issuer_ticker":"HILS","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":0.7799,"price_display":"0.78","price_state":"stated","total_value":389.95,"total_display":"389.95","total_whole":"390","shares_owned_after":2937940.0,"shares_owned_after_display":"2,937,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-17","filed_date":"2022-06-21","scope":"insider"},{"id":6391975,"accession":"0001493152-22-016088","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001493152-22-016088","line_url":"/filing/0001493152-22-016088","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"Hillstream BioPharma Inc.","issuer_ticker":"HILS","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.6884632,"price_display":"0.69","price_state":"stated","total_value":688.4632,"total_display":"688.46","total_whole":"688","shares_owned_after":2938540.0,"shares_owned_after_display":"2,938,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-07","scope":"insider","n_lines":5},{"id":6224115,"accession":"0001493152-22-015724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-015724","line_url":"/filing/0001493152-22-015724#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"Hillstream BioPharma Inc.","issuer_ticker":"HILS","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1.0,"shares_display":"1","price_per_share":0.94,"price_display":"0.94","price_state":"stated","total_value":0.94,"total_display":"0.94","total_whole":"1","shares_owned_after":2937540.0,"shares_owned_after_display":"2,937,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider"},{"id":6936239,"accession":"0001493152-22-015080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-015080","line_url":"/filing/0001493152-22-015080","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"Hillstream BioPharma Inc.","issuer_ticker":"HILS","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.786,"price_display":"0.79","price_state":"stated","total_value":786.0,"total_display":"786.00","total_whole":"786","shares_owned_after":2937539.0,"shares_owned_after_display":"2,937,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-25","scope":"insider","n_lines":2},{"id":6726007,"accession":"0001493152-22-014792","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-014792","line_url":"/filing/0001493152-22-014792","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"Hillstream BioPharma Inc.","issuer_ticker":"HILS","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.91825,"price_display":"0.92","price_state":"stated","total_value":918.25,"total_display":"918.25","total_whole":"918","shares_owned_after":2936539.0,"shares_owned_after_display":"2,936,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-23","scope":"insider","n_lines":2},{"id":6327783,"accession":"0001493152-22-014500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-014500","line_url":"/filing/0001493152-22-014500","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"Hillstream BioPharma Inc.","issuer_ticker":"HILS","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.90765,"price_display":"0.91","price_state":"stated","total_value":907.65,"total_display":"907.65","total_whole":"908","shares_owned_after":2935039.0,"shares_owned_after_display":"2,935,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-19","scope":"insider","n_lines":2},{"id":8298479,"accession":"0001144204-15-040393","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-040393","line_url":"/filing/0001144204-15-040393#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1610.0,"shares_display":"1,610","price_per_share":3.88,"price_display":"3.88","price_state":"stated","total_value":6246.8,"total_display":"6,246.80","total_whole":"6,247","shares_owned_after":57026.0,"shares_owned_after_display":"57,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-30","filed_date":"2015-07-01","scope":"insider"},{"id":8501228,"accession":"0001144204-15-037478","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-037478","line_url":"/filing/0001144204-15-037478#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1245.0,"shares_display":"1,245","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":6249.9,"total_display":"6,249.90","total_whole":"6,250","shares_owned_after":55416.0,"shares_owned_after_display":"55,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-16","scope":"insider"},{"id":8608910,"accession":"0001144204-15-034820","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-034820","line_url":"/filing/0001144204-15-034820#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1026.0,"shares_display":"1,026","price_per_share":6.09,"price_display":"6.09","price_state":"stated","total_value":6248.34,"total_display":"6,248.34","total_whole":"6,248","shares_owned_after":54171.0,"shares_owned_after_display":"54,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-29","filed_date":"2015-06-01","scope":"insider"},{"id":8861982,"accession":"0001144204-15-032249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-032249","line_url":"/filing/0001144204-15-032249#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":979.0,"shares_display":"979","price_per_share":6.38,"price_display":"6.38","price_state":"stated","total_value":6246.02,"total_display":"6,246.02","total_whole":"6,246","shares_owned_after":53145.0,"shares_owned_after_display":"53,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-15","filed_date":"2015-05-19","scope":"insider"},{"id":8800587,"accession":"0001144204-15-023553","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-023553","line_url":"/filing/0001144204-15-023553#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":730.0,"shares_display":"730","price_per_share":8.55,"price_display":"8.55","price_state":"stated","total_value":6241.5,"total_display":"6,241.50","total_whole":"6,242","shares_owned_after":52166.0,"shares_owned_after_display":"52,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-15","filed_date":"2015-04-17","scope":"insider"},{"id":8364624,"accession":"0001144204-15-013646","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-013646","line_url":"/filing/0001144204-15-013646#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1211.0,"shares_display":"1,211","price_per_share":5.16,"price_display":"5.16","price_state":"stated","total_value":6248.76,"total_display":"6,248.76","total_whole":"6,249","shares_owned_after":51436.0,"shares_owned_after_display":"51,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-27","filed_date":"2015-03-03","scope":"insider"},{"id":8500853,"accession":"0001144204-15-010682","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-010682","line_url":"/filing/0001144204-15-010682#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1911.0,"shares_display":"1,911","price_per_share":3.27,"price_display":"3.27","price_state":"stated","total_value":6248.97,"total_display":"6,248.97","total_whole":"6,249","shares_owned_after":50225.0,"shares_owned_after_display":"50,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-13","filed_date":"2015-02-18","scope":"insider"},{"id":8567838,"accession":"0001144204-15-005355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-005355","line_url":"/filing/0001144204-15-005355#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2016.0,"shares_display":"2,016","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":6249.6,"total_display":"6,249.60","total_whole":"6,250","shares_owned_after":48314.0,"shares_owned_after_display":"48,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-30","filed_date":"2015-02-02","scope":"insider"},{"id":8567747,"accession":"0001144204-15-000122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-000122","line_url":"/filing/0001144204-15-000122#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3272.0,"shares_display":"3,272","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":6249.52,"total_display":"6,249.52","total_whole":"6,250","shares_owned_after":46298.0,"shares_owned_after_display":"46,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-31","filed_date":"2015-01-02","scope":"insider"},{"id":6606937,"accession":"0001144204-14-074282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-074282","line_url":"/filing/0001144204-14-074282#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4734.0,"shares_display":"4,734","price_per_share":1.32,"price_display":"1.32","price_state":"stated","total_value":6248.88,"total_display":"6,248.88","total_whole":"6,249","shares_owned_after":43026.0,"shares_owned_after_display":"43,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6405052,"accession":"0001144204-14-071871","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-071871","line_url":"/filing/0001144204-14-071871#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4464.0,"shares_display":"4,464","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":6249.6,"total_display":"6,249.60","total_whole":"6,250","shares_owned_after":38292.0,"shares_owned_after_display":"38,292","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-28","filed_date":"2014-12-02","scope":"insider"},{"id":6378891,"accession":"0001144204-14-069535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-069535","line_url":"/filing/0001144204-14-069535#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4111.0,"shares_display":"4,111","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":6248.72,"total_display":"6,248.72","total_whole":"6,249","shares_owned_after":33828.0,"shares_owned_after_display":"33,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-14","filed_date":"2014-11-18","scope":"insider"},{"id":6200387,"accession":"0001144204-14-064811","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-064811","line_url":"/filing/0001144204-14-064811#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3434.0,"shares_display":"3,434","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":6249.88,"total_display":"6,249.88","total_whole":"6,250","shares_owned_after":29717.0,"shares_owned_after_display":"29,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-31","filed_date":"2014-11-04","scope":"insider"},{"id":6453726,"accession":"0001144204-14-061601","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-061601","line_url":"/filing/0001144204-14-061601#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4058.0,"shares_display":"4,058","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":6249.32,"total_display":"6,249.32","total_whole":"6,249","shares_owned_after":26283.0,"shares_owned_after_display":"26,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-15","filed_date":"2014-10-17","scope":"insider"},{"id":6513170,"accession":"0001144204-14-059124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-059124","line_url":"/filing/0001144204-14-059124#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3324.0,"shares_display":"3,324","price_per_share":1.88,"price_display":"1.88","price_state":"stated","total_value":6249.12,"total_display":"6,249.12","total_whole":"6,249","shares_owned_after":22225.0,"shares_owned_after_display":"22,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-30","filed_date":"2014-10-02","scope":"insider"},{"id":6453689,"accession":"0001144204-14-056226","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-056226","line_url":"/filing/0001144204-14-056226#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3654.0,"shares_display":"3,654","price_per_share":1.71,"price_display":"1.71","price_state":"stated","total_value":6248.34,"total_display":"6,248.34","total_whole":"6,248","shares_owned_after":18901.0,"shares_owned_after_display":"18,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-15","filed_date":"2014-09-16","scope":"insider"},{"id":6200170,"accession":"0001144204-14-053757","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-053757","line_url":"/filing/0001144204-14-053757#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3125.0,"shares_display":"3,125","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":6250.0,"total_display":"6,250.00","total_whole":"6,250","shares_owned_after":15247.0,"shares_owned_after_display":"15,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-29","filed_date":"2014-09-02","scope":"insider"},{"id":6902389,"accession":"0001144204-14-051065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-051065","line_url":"/filing/0001144204-14-051065#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3140.0,"shares_display":"3,140","price_per_share":1.99,"price_display":"1.99","price_state":"stated","total_value":6248.6,"total_display":"6,248.60","total_whole":"6,249","shares_owned_after":12122.0,"shares_owned_after_display":"12,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-15","filed_date":"2014-08-18","scope":"insider"},{"id":6513104,"accession":"0001144204-14-046437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-046437","line_url":"/filing/0001144204-14-046437#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6250.0,"shares_display":"6,250","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":12500.0,"total_display":"12,500.00","total_whole":"12,500","shares_owned_after":8982.0,"shares_owned_after_display":"8,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-31","filed_date":"2014-08-01","scope":"insider"},{"id":6606596,"accession":"0001144204-14-041084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-041084","line_url":"/filing/0001144204-14-041084#line-1","is_derivative":false,"issuer_cik":"0001360968","issuer_name":"CorMedix Inc.","issuer_ticker":"CRMD","issuer_name_source":null,"issuer_url":"/issuer/0001360968","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2732.0,"shares_display":"2,732","price_per_share":1.83,"price_display":"1.83","price_state":"stated","total_value":4999.56,"total_display":"4,999.56","total_whole":"5,000","shares_owned_after":2732.0,"shares_owned_after_display":"2,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-30","filed_date":"2014-07-02","scope":"insider"},{"id":3547077,"accession":"0001144204-06-038604","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-06-038604","line_url":"/filing/0001144204-06-038604#line-1","is_derivative":false,"issuer_cik":"0001355015","issuer_name":"TENBY PHARMA INC","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001355015","owner_cik":"0001360968","owner_name":"MILBY RANDY","owner_display_name":"MILBY RANDY","owner_url":"/insider/0001360968","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250000.0,"shares_display":"2,250,000","price_per_share":0.0001,"price_display":"0.00","price_state":"stated","total_value":225.0,"total_display":"225.00","total_whole":"225","shares_owned_after":250000.0,"shares_owned_after_display":"250,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-09-13","filed_date":"2006-09-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":39,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001861657","name":"Tharimmune, Inc.","url":"/issuer/0001861657","role":"Director, Officer (CEO), Ten percent owner","n_filings":10,"first_seen":"2022-05-19","last_seen":"2024-12-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001410098","name":"CorMedix Inc.","url":"/issuer/0001410098","role":"Director, Officer (Chief Executive Officer)","n_filings":20,"first_seen":"2014-07-02","last_seen":"2015-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001355015","name":"TENBY PHARMA INC","url":"/issuer/0001355015","role":"Other","n_filings":1,"first_seen":"2006-09-15","last_seen":"2006-09-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001360968","retrieved_at":"2026-08-26T06:49:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}